Cargando…

Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain

Worldwide, an ever-increasing number of women are prescribed estrogen-modulating therapies (EMTs) for the treatment of breast cancer. In parallel, aging of the global population of women will contribute to risk of both breast cancer and Alzheimer’s disease. To address the impact of anti-estrogen the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Branigan, Gregory L., Torrandell-Haro, Georgina, Chen, Shuhua, Shang, Yuan, Perez-Miller, Samantha, Mao, Zisu, Padilla-Rodriguez, Marco, Cortes-Flores, Helena, Vitali, Francesca, Brinton, Roberta Diaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663748/ https://www.ncbi.nlm.nih.gov/pubmed/38026173 http://dx.doi.org/10.1016/j.isci.2023.108316

Ejemplares similares

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020)

Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients
por: Torrandell-Haro, Georgina, et al.
Publicado: (2022)

Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
por: Branigan, Gregory L., et al.
Publicado: (2022)

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
por: Branigan, Gregory L., et al.
Publicado: (2022)

Preventing Alzheimer's disease within reach by 2025: Targeted‐risk‐AD‐prevention (TRAP) strategy
por: Vitali, Francesca, et al.
Publicado: (2021)

2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer's Disease
por: Yao, Jia, et al.
Publicado: (2011)

Ovariectomy Induces a Shift in Fuel Availability and Metabolism in the Hippocampus of the Female Transgenic Model of Familial Alzheimer's
por: Ding, Fan, et al.
Publicado: (2013)

Select estrogens within the complex formulation of conjugated equine estrogens (Premarin(®)) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease
por: Zhao, Liqin, et al.
Publicado: (2006)

Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2012)

Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function
por: Nilsen, Jon, et al.
Publicado: (2006)

Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice
por: Shang, Yuan, et al.
Publicado: (2020)

Association Between Hormone-Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes for Women With Breast Cancer
por: Branigan, Gregory L., et al.
Publicado: (2020)

Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy
por: Kim, Yu Jin, et al.
Publicado: (2021)

Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention
por: Ding, Fan, et al.
Publicado: (2013)

Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
por: Chen, Shuhua, et al.
Publicado: (2011)

Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks
por: Rahman, Aneela, et al.
Publicado: (2019)

Contributions of sex and genotype to exploratory behavior differences in an aged humanized APOE mouse model of late-onset Alzheimer's disease
por: McLean, John W., et al.
Publicado: (2022)

Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention
por: Jett, Steven, et al.
Publicado: (2022)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

Continuous versus Cyclic Progesterone Exposure Differentially Regulates Hippocampal Gene Expression and Functional Profiles
por: Zhao, Liqin, et al.
Publicado: (2012)

Estrogen-repressed genes – key mediators of estrogen action?
por: Zubairy, Simeen, et al.
Publicado: (2005)

The Influence of Estrogens on the Biological and Therapeutic Actions of Growth Hormone in the Liver
por: de Mirecki-Garrido, Mercedes, et al.
Publicado: (2012)

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
por: Geifman, Nophar, et al.
Publicado: (2017)

Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
por: Mishra, Aarti, et al.
Publicado: (2018)

Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer’s Risk in Female Brain
por: Wang, Yiwei, et al.
Publicado: (2020)

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
por: Ming Wang, Jun, et al.
Publicado: (2007)

Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
por: Nilsson , Stefan, et al.
Publicado: (2000)

Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex
por: Wang, Yiwei, et al.
Publicado: (2016)

Data-driven identification of endophenotypes of Alzheimer’s disease progression: implications for clinical trials and therapeutic interventions
por: Geifman, Nophar, et al.
Publicado: (2018)

Dynamic Neuroimmune Profile during Mid-life Aging in the Female Brain and Implications for Alzheimer Risk
por: Mishra, Aarti, et al.
Publicado: (2020)

The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens.
por: Watson, C S, et al.
Publicado: (1995)

Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk
por: Barthold, Douglas, et al.
Publicado: (2020)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

Estrogen Biosynthesis and Action in Ovarian Cancer
por: Mungenast, Felicitas, et al.
Publicado: (2014)

Molecular Pathways of Estrogen Receptor Action
por: Pakdel, Farzad
Publicado: (2018)

Estrogen activates Alzheimer's disease genes
por: Ratnakumar, Abhirami, et al.
Publicado: (2019)

Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2013)

Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer
por: Blanchard, Zannel, et al.
Publicado: (2019)

Session Summary: Nontraditional Sites of Estrogen Action
por: Metzger, Deborah A.
Publicado: (1995)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lf4f4gqaeq0cg7ai4r7afo9qgk